MRC1 and endometrial carcinoma: While the presence of microsatellite instability was independently associated with a more favorable clinical outcome in endometrial carcinoma [35], other studies demonstrated that young women (younger than 40 or 60 years) with loss of MMR proteins were at risk of high-grade tumors with poor clinical outcomes [32–34].